Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251498
Status:
COMPLETED
Last Update Posted:
2008-08-21
First Post:
2005-11-08
Brief Title:
Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
Veeda Oncology
Organization:
Veeda Oncology
Organization Data
Organization:
Veeda Oncology
Class:
OTHER
Study ID:
I-04-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Veeda Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |